We're Sorry
This commercial has been removed at the request of the advertiser

Gold Shield Group TV Commercial, 'Type-2 Diabetes Medication Side Effects'

Ad ID: 2217270    60s    2018 ( Inactive )

Gold Shield Group announces that various medications such as Invokana, Invokamet, Jardiance and Farxiga are linked to an increased risk of toe, leg and foot amputations. Type-2 Diabetics who suffered serious side effects after taking these medications are encouraged to call and file a claim.

Advertiser Profiles
Songs - Add
None have been identified for this spot
Phone
888-435-7861
Mood
Informational
Actors - Add
None have been identified for this spot

More Gold Shield Group Commercials
Related Commercials

Unlock These Metrics

Free 10 days of access on all ads

Media Measurement

National Airings
First Airing
Last Airing
Creatives
Est. Spend
TV Impressions
National
Local
VOD/OTT

Attention & Performance Analytics

Attention Score
Industry Avg.
Earned Online Views
Social Impressions
Sentiment
Engagement Rating
Industry Share of Voice
Spend
Impressions
Engagement
Back to top